Needham & Company LLC Reaffirms Hold Rating for Envista (NYSE:NVST)

Envista (NYSE:NVST)‘s stock had its “hold” rating reiterated by equities researchers at Needham & Company LLC in a research report issued to clients and investors on Thursday,Benzinga reports.

Other analysts have also issued research reports about the stock. Leerink Partnrs upgraded shares of Envista from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 31st. Jefferies Financial Group lifted their price objective on shares of Envista from $20.00 to $22.00 and gave the company a “hold” rating in a research note on Thursday, January 23rd. Piper Sandler lifted their price objective on shares of Envista from $17.00 to $18.00 and gave the company a “neutral” rating in a research note on Monday, February 3rd. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and boosted their price target for the company from $16.00 to $23.00 in a research note on Thursday, October 31st. Finally, Stifel Nicolaus boosted their price target on shares of Envista from $18.00 to $21.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Two analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $20.21.

Envista Stock Down 2.4 %

Shares of NYSE NVST opened at $21.27 on Thursday. The company has a market capitalization of $3.66 billion, a P/E ratio of -2.74, a price-to-earnings-growth ratio of 1.82 and a beta of 1.34. Envista has a 52-week low of $15.15 and a 52-week high of $23.06. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.77 and a current ratio of 2.08. The company’s 50 day moving average price is $19.96 and its 200-day moving average price is $19.12.

Envista (NYSE:NVST) last released its quarterly earnings data on Wednesday, February 5th. The company reported $0.24 earnings per share for the quarter, beating the consensus estimate of $0.23 by $0.01. Envista had a negative net margin of 53.42% and a positive return on equity of 3.76%. Equities analysts forecast that Envista will post 0.72 earnings per share for the current year.

Institutional Trading of Envista

Several institutional investors have recently made changes to their positions in the company. Pzena Investment Management LLC bought a new stake in shares of Envista in the 4th quarter worth $16,979,000. Zurcher Kantonalbank Zurich Cantonalbank grew its stake in shares of Envista by 17.7% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 42,057 shares of the company’s stock worth $811,000 after acquiring an additional 6,320 shares in the last quarter. Raymond James Financial Inc. purchased a new position in shares of Envista in the 4th quarter worth about $10,808,000. Proficio Capital Partners LLC purchased a new position in shares of Envista in the 4th quarter worth about $358,000. Finally, M&T Bank Corp boosted its holdings in shares of Envista by 4.2% in the 4th quarter. M&T Bank Corp now owns 16,621 shares of the company’s stock worth $320,000 after buying an additional 676 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.